Nuclear medicine significantly contributes to cancer diagnosis and tumor grading.
The potential to identify and characterize cancer lesions is fundamental for the accuracy of tumor staging, for the identification of tumor relapse and/or progression, as well as for the definition of metastatic disease. Accurate diagnosis and staging are essential to choose the most suitable treatment for an individual patient's tumor and to predict their response.
In this Research Topic, we aim to collect the recent advances and state of art in nuclear medicine in cancer diagnosis.
Special emphasis will be given to molecular imaging techniques and the development of new radiopharmaceuticals for cancer diagnosis. Manuscripts on hybrid imaging modalities are also welcome.
Nuclear medicine significantly contributes to cancer diagnosis and tumor grading.
The potential to identify and characterize cancer lesions is fundamental for the accuracy of tumor staging, for the identification of tumor relapse and/or progression, as well as for the definition of metastatic disease. Accurate diagnosis and staging are essential to choose the most suitable treatment for an individual patient's tumor and to predict their response.
In this Research Topic, we aim to collect the recent advances and state of art in nuclear medicine in cancer diagnosis.
Special emphasis will be given to molecular imaging techniques and the development of new radiopharmaceuticals for cancer diagnosis. Manuscripts on hybrid imaging modalities are also welcome.